Gelonghui, December 8, Renhe Pharmaceutical (000650.SZ) announced that on December 8, 2023, for the first time, the company repurchased 570,000 shares of the company through centralized bidding through a special stock repurchase account, accounting for 0.04% of the company's current total share capital, with a maximum transaction price of 6.78 yuan/share and a minimum transaction price of 6.77 yuan/share, with a total transaction amount of 3.8625 million yuan (excluding transaction fees).
仁和药业(000650.SZ)：首次回购57万股 涉资386.25万元
Renhe Pharmaceutical (000650.SZ): The initial repurchase of 570,000 shares involved 38625 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.